Kanghua Biotech (300841.SZ): Has repurchased a total of 0.85% of shares

Gelonghui, May 6, 丨 Kanghua Biotech (300841.SZ) announced that as of April 30, 2024, the company had repurchased 1,150,000 shares of the company's shares through a special stock repurchase securities account, accounting for 0.85% of the company's current total share capital. The highest transaction price was 63.26 yuan/share, the minimum transaction price was 45.97 yuan/share, and the total transaction amount was 2,6432,617.41 yuan (excluding transaction fees).

Gelonghui FinanceMay 6 19:27

Kanghua Biotech (300841): A year-on-year improvement on the down payment cost side of receiving the Noro vaccine overseas transfer agreement

Core idea On April 23, the company released its report for the first quarter of 2024. The revenue side growth was mainly due to receiving a $15 million down payment from HillEvax. R&D expenses have dropped dramatically, leading to significant profit side growth

中信建投證券May 6 13:36

Kanghua Biology (300841): Noro vaccine is progressing smoothly in overseas diploid rabies vaccine continues to grow

Revenue continued to grow in 2023, and operating cash flow improved markedly. The company's 2023 revenue was 1.58 billion yuan, up 9% year on year, net profit due to mother was 510 million yuan, down 15% year on year, and net profit not returned to mother was 540 million yuan

海通國際May 3 00:00

Kanghua Biotech (300841) 2023 and 24Q1 Quarterly Report: Noro Vaccine Goes Overseas, Diploid Rabies Vaccine Continues to Grow

Revenue continued to grow in 2023, and operating cash flow improved markedly. The company's revenue in 2023 was 1.58 billion yuan, up 9% year on year, net profit due to mother was 510 million yuan, down 15% year on year, net profit after deducting non-return to mother 540 million yuan

海通證券Apr 30 16:22

Gao Yi's path to transfer positions came to light. Qiu Guolu, Feng Liu, and Deng Xiaofeng each reduced their holdings, and chemical and pharmaceutical stocks frequently increased their positions

① Feng Liu has continuously reduced his holdings of Hikvision, Zhongju Hi-Tech, and Baofeng Energy, and increased his holdings of pharmaceutical and chemical stocks in the first quarter; ② Deng Xiaofeng reduced his holdings of Zijin Mining, Yunlu, and China Aluminum by 3 mining stocks and has withdrawn from the top ten tradable shareholders of Wanhua Chemical; ③ Qiu Guolu also continuously reduced his holdings in the mining industry Tiandi Technology.

cls.cnApr 28 18:21

Kanghua Biotech (300841.SZ) plans to pay 20 yuan for 10 shares to be deducted from interest on May 8

Zhitong Finance App News, Kanghua Biotech (300841.SZ) announced that the company's 2023 equity distribution plan: a cash dividend of 20 yuan (tax included) for every 10 shares to all shareholders. The ex-dividend date is: May 8, 2024.

Zhitong FinanceApr 26 21:56